Tuberculosis Diagnostics Global Market Report 2024

Description

Tuberculosis diagnostics encompass tools or tests characterized by high sensitivity and specificity in diagnosing TB and monitoring treatment effectiveness. They aim to identify acid-fast bacilli (AFB) in clinical samples and detect tuberculosis.

The tuberculosis diagnostics market comprises various types of tests such as radiographic testing, laboratory testing, nucleic acid testing, cytokine detection testing, drug resistance testing, skin test (TST)/Mantoux test, blood/serology tests, smear microscopy tests, cell culture-based tests, and other methods. Radiographic tests are utilized to identify chest abnormalities indicative of tuberculosis symptoms. These tests focus on diagnosing lesions that can manifest anywhere in the lungs, differing in cavitation, density, size, and shape. These diagnostic methods encompass nucleic acid testing (NAT), skin testing or Mantoux test (TST), blood testing or serology tests, smear microscopy, cultured-based tests, radiography tests, and other approaches. They serve various disease stages such as latent tuberculosis and active tuberculosis. End-users of tuberculosis diagnostics include hospitals, diagnostic laboratories, physician's office laboratories, reference laboratories, academic institutions, and research facilities.

The tuberculosis diagnostics market research report is one of a series of new reports from The Business Research Company that provides tuberculosis diagnostics market statistics, including tuberculosis diagnostics industry global market size, regional shares, competitors with a tuberculosis diagnostics market share, detailed tuberculosis diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the tuberculosis diagnostics industry. This tuberculosis diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The tuberculosis diagnostics market size has grown strongly in recent years. It will grow from $2.11 billion in 2023 to $2.27 billion in 2024 at a compound annual growth rate (CAGR) of 7.7%. The expansion observed during the historical period can be attributed to several factors. These include an increase in tuberculosis cases, higher healthcare spending, a rise in the number of healthcare facilities, and increased adoption of nucleic acid testing methods.

The tuberculosis diagnostics market size is expected to see strong growth in the next few years. It will grow to $3.02 billion in 2028 at a compound annual growth rate (CAGR) of 7.4%. Forecasted growth is driven by strong government support, increased FDA approvals for TB diagnostics, growing R&D, and the emergence of drug-resistant TB. Key trends include NGS platform adoption, product innovations, T cell tests, AI integration, portable device use, and government-manufacturer collaborations.

The surge in tuberculosis cases is a key driver behind the escalating demand for tuberculosis diagnostics, underscoring the market's growth trajectory. Tuberculosis, an infectious respiratory disease, poses a significant health threat and spreads through airborne particles released during coughing and sneezing. Tuberculosis diagnostics play a crucial role in the early detection and diagnosis of the disease. A notable example of this trend is evident in the Centers for Disease Control and Prevention's weekly report in March 2022, revealing a 9.4% increase in tuberculosis infections in the United States in 2021. The total reported cases reached 7,860, compared to 7,173 cases in the preceding year. Consequently, the rising incidence of tuberculosis is a key factor propelling the expansion of the tuberculosis diagnostics market.

The growing number of approvals from the US Food and Drug Administration (FDA) for tuberculosis diagnostics will further bolster market growth. An illustrative instance is the announcement made in March 2023 by PerkinElmer Oxford Immunotec, a UK-based medical diagnostics company, regarding the FDA approval for the use of two additional cell isolation instruments, Auto-Pure 24 and Auto-Pure 20B platforms, manufactured by Allsheng Instruments. Additionally, in October 2022, PerkinElmer Oxford Immunotec received FDA approval for the use of the T-Cell Select reagent kit, facilitating the automation of the T-SPOT.TB test workflow for in vitro diagnostic (IVD) use by certified laboratories. T-Cell Select, a peripheral blood mononuclear cell (PBMC) isolation reagent, employs positive selection of PBMCs with magnetic bead-based cell separation to streamline the preparation of cells for the T-SPOT.TB test-an internationally regulated ELISPOT IGRA designed for detecting latent tuberculosis infection. This influx of FDA approvals for novel tuberculosis diagnostics is anticipated to reinforce and drive the growth of the tuberculosis diagnostics market.

The prevailing trend shaping the tuberculosis diagnostics market is the adoption of technological innovations, with major market players actively integrating advanced technologies to maintain their market standing. Notably, companies are introducing sophisticated point-of-care (POC) diagnostic methods leveraging artificial intelligence (AI) technology. A case in point is the collaboration between Fujifilm, a Japan-based medical imaging device manufacturer, and Qure.ai, a US-based company specializing in AI-enabled medical imaging solutions. In August 2022, they jointly launched an advanced POC diagnostic method utilizing a battery-powered X-ray machine for tuberculosis diagnosis. The integration of artificial intelligence algorithms enhances testing programs, offering ultra-portability, high accuracy, and efficient solutions for point-of-care diagnostics.

A prominent trend in the tuberculosis diagnostics market is the emphasis on product innovations as companies strive to remain competitive and meet evolving consumer needs and preferences. Product innovation plays a pivotal role in generating enthusiasm, driving sales, and increasing brand awareness. Companies in the tuberculosis diagnostics sector are actively focusing on developing new product solutions to fortify their market positions. A noteworthy example is Redcliffe Labs, an India-based technology-empowered diagnostics service provider, which, in February 2023, introduced the BD MAX MDR TB (Tuberculosis) test. This diagnostic test, performed on the BD MAX molecular diagnostic system, enables clinicians to rapidly test for tuberculosis and multidrug resistance as a first-line test. Clinicians use the test to simultaneously detect bacteria causing TB and ascertain whether the bacteria exhibit mutations associated with resistance to two vital first-line drugs, Isoniazid (INH) and Rifampicin (RIF). This focus on product innovation is integral to strengthening companies' positions within the tuberculosis diagnostics market.

In March 2021, PerkinElmer, a US diagnostics and scientific research company, acquired Oxford Immunotec for $591 million. This strategic move enables PerkinElmer to broaden its portfolio of infectious disease testing solutions, particularly enhancing tuberculosis detection capabilities, catering to a global clientele. Oxford Immunotec, a UK-based company specializing in proprietary assays for immunology and infectious diseases, strengthens PerkinElmer's position in this critical sector.

Major companies operating in the tuberculosis diagnostics market report are Beckton, Dickinson and Company, F. Hoffmann-La Roche Ltd., Qiagen N.V, BioMerieux SA, Danaher Corporation, PerkinElmer, Thermo Fisher Scientific Inc., Creative Diagnostics, Lionex GmbH, Biocartis, Bio-Techne India Private Limited, Bio-Rad laboratories India Pvt.Ltd., Zhejiang Di'an Diagnostics Technology Co., Ltd., ADICON Clinical Laboratories, Guangzhou Kingmed Diagnostics Center Co. Ltd., Kindstar Global, OriGene Technologies, Siemens AG, Fresenius, Koninklijke Philips, Novartis, LumiraDx Limited, TestLine Clinical Diagnostics s.r.o., Hologic, Bayer AG, Cantel Medical Corporation, Meridian Bioscience, Johnson & Johnson, Abbott laboratories Immunodiagnostic Systems Holdings PLC, Mesa Biotech Inc, Pfizer, Agilent technologies Inc, AutoGenomics, AdvaCare Pharma, Akonni Biosystems Inc, Par Pharmaceutical, Epistem Limited, Gen-Probe, Sysmex South Africa (Pty) Ltd., Grifols S.A., Bio Certica, Biovac, BixBio

Asia-Pacific was the largest region in the tuberculosis diagnostics market in 2023. The regions covered in the tuberculosis diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the tuberculosis diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The tuberculosis diagnostics market includes revenues earned by entities by providing services related to diagnostic laboratory methods, detection of latent infection, detection of drug resistance, and diagnostic laboratory testings. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Tuberculosis Diagnostics Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on tuberculosis diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for tuberculosis diagnostics? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The tuberculosis diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

1) By Test Type: Radiographic Tests; Nucleic Acid Testing; Cytokine Detection Tests; Drug Resistance Tests; Skin Test / Mantoux Test (TST); Blood/Serology Test; Smear Microscopy Tests; Cell Culture-Based Tests; Other Test Types
2) By Disease Stage: Latent Tuberculosis; Active Tuberculosis
3) By End-User: Hospitals And Diagnostic Laboratories; Physician's Office Laboratories; Reference Laboratories; Academics And Research Facilities
Companies Mentioned: Beckton, Dickinson and Company; F. Hoffmann-La Roche Ltd; Qiagen N.V; BioMerieux SA; Danaher Corporation
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.

Product Code: r14942

1. Executive Summary

2. Tuberculosis Diagnostics Market Characteristics

3. Tuberculosis Diagnostics Market Trends And Strategies

4. Tuberculosis Diagnostics Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market

5. Global Tuberculosis Diagnostics Market Size and Growth

5.1. Global Tuberculosis Diagnostics Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Tuberculosis Diagnostics Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Tuberculosis Diagnostics Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Tuberculosis Diagnostics Market Segmentation

6.1. Global Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Radiographic Tests
Nucleic Acid Testing
Cytokine Detection Tests
Drug Resistance Tests
Skin Test / Mantoux Test (TST)
Blood/Serology Test
Smear Microscopy Tests
Cell Culture-Based Tests
Other Test Types
6.2. Global Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Latent Tuberculosis
Active Tuberculosis
6.3. Global Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Hospitals And Diagnostic Laboratories
Physician's Office Laboratories
Reference Laboratories
Academics And Research Facilities

7. Tuberculosis Diagnostics Market Regional And Country Analysis

7.1. Global Tuberculosis Diagnostics Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Tuberculosis Diagnostics Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Tuberculosis Diagnostics Market

8.1. Asia-Pacific Tuberculosis Diagnostics Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Tuberculosis Diagnostics Market

9.1. China Tuberculosis Diagnostics Market Overview
9.2. China Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Tuberculosis Diagnostics Market

10.1. India Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Tuberculosis Diagnostics Market

11.1. Japan Tuberculosis Diagnostics Market Overview
11.2. Japan Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Tuberculosis Diagnostics Market

12.1. Australia Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Tuberculosis Diagnostics Market

13.1. Indonesia Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Tuberculosis Diagnostics Market

14.1. South Korea Tuberculosis Diagnostics Market Overview
14.2. South Korea Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Tuberculosis Diagnostics Market

15.1. Western Europe Tuberculosis Diagnostics Market Overview
15.2. Western Europe Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Tuberculosis Diagnostics Market

16.1. UK Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Tuberculosis Diagnostics Market

17.1. Germany Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Tuberculosis Diagnostics Market

18.1. France Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Tuberculosis Diagnostics Market

19.1. Italy Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Tuberculosis Diagnostics Market

20.1. Spain Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Tuberculosis Diagnostics Market

21.1. Eastern Europe Tuberculosis Diagnostics Market Overview
21.2. Eastern Europe Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Tuberculosis Diagnostics Market

22.1. Russia Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Tuberculosis Diagnostics Market

23.1. North America Tuberculosis Diagnostics Market Overview
23.2. North America Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Tuberculosis Diagnostics Market

24.1. USA Tuberculosis Diagnostics Market Overview
24.2. USA Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Tuberculosis Diagnostics Market

25.1. Canada Tuberculosis Diagnostics Market Overview
25.2. Canada Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Tuberculosis Diagnostics Market

26.1. South America Tuberculosis Diagnostics Market Overview
26.2. South America Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Tuberculosis Diagnostics Market

27.1. Brazil Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Tuberculosis Diagnostics Market

28.1. Middle East Tuberculosis Diagnostics Market Overview
28.2. Middle East Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Tuberculosis Diagnostics Market

29.1. Africa Tuberculosis Diagnostics Market Overview
29.2. Africa Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Tuberculosis Diagnostics Market Competitive Landscape And Company Profiles

30.1. Tuberculosis Diagnostics Market Competitive Landscape
30.2. Tuberculosis Diagnostics Market Company Profiles
- 30.2.1. Beckton, Dickinson and Company
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. F. Hoffmann-La Roche Ltd
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. Qiagen N.V
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. BioMerieux SA
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. Danaher Corporation
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Tuberculosis Diagnostics Market Other Major And Innovative Companies

31.1. PerkinElmer
31.2. Thermo Fisher Scientific Inc.
31.3. Creative Diagnostics
31.4. Lionex GmbH
31.5. Biocartis
31.6. Bio-Techne India Private Limited
31.7. Bio-Rad laboratories India Pvt.Ltd
31.8. Zhejiang Di'an Diagnostics Technology Co., Ltd
31.9. ADICON Clinical Laboratories
31.10. Guangzhou Kingmed Diagnostics Center Co. Ltd.
31.11. Kindstar Global
31.12. OriGene Technologies
31.13. Siemens AG
31.14. Fresenius
31.15. Koninklijke Philips

32. Global Tuberculosis Diagnostics Market Competitive Benchmarking

33. Global Tuberculosis Diagnostics Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Tuberculosis Diagnostics Market

35. Tuberculosis Diagnostics Market Future Outlook and Potential Analysis

35.1 Tuberculosis Diagnostics Market In 2028 - Countries Offering Most New Opportunities
35.2 Tuberculosis Diagnostics Market In 2028 - Segments Offering Most New Opportunities
35.3 Tuberculosis Diagnostics Market In 2028 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer